NASDAQ:BLTE

Belite Bio Stock Predictions

Healthcare > Biotechnology

Buy BLTE

*Your capital is at risk

$137.23

+2.30 (+1.70%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

BLTE Prediction Chart

BLTE Predictions History

Latest community submissions for BLTE.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Jul 12, 2022	$39.04 -3.56%	$38.91	V	99.67%	5
Jerry Huang @JerryHuang.334113	Jul 12, 2022	Bullish	$38.91	X	—	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BLTE with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT BELITE BIO, INC

Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by